Inflammasome-Induced Osmotic Pressure and the Mechanical Mechanisms Underlying Astrocytic Swelling and Membrane Blebbing in Pyroptosis

Cell swelling and membrane blebbing are characteristic of pyroptosis. In the present study, we explored the role of intracellular tension activity in the deformation of pyroptotic astrocytes. Protein nanoparticle-induced osmotic pressure (PN-OP) was found to be involved in cell swelling and membrane...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 12; p. 688674
Main Authors Zheng, Zihui, Wang, Tingting, Chen, Jiahui, Qiu, Huimin, Zhang, Chencheng, Liu, Weizhen, Qin, Simiao, Tian, Jilai, Guo, Jun
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 07.07.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cell swelling and membrane blebbing are characteristic of pyroptosis. In the present study, we explored the role of intracellular tension activity in the deformation of pyroptotic astrocytes. Protein nanoparticle-induced osmotic pressure (PN-OP) was found to be involved in cell swelling and membrane blebbing in pyroptotic astrocytes, and was associated closely with inflammasome production and cytoskeleton depolymerization. However, accumulation of protein nanoparticles seemed not to be absolutely required for pyroptotic permeabilization in response to cytoskeleton depolymerization. Gasdermin D activation was observed to be involved in modification of typical pyroptotic features through inflammasome-induced OP upregulation and calcium increment. Blockage of nonselective ion pores can inhibit permeabilization, but not inflammasome production and ion influx in pyroptotic astrocytes. The results suggested that the inflammasomes, as protein nanoparticles, are involved in PN-OP upregulation and control the typical features of pyroptotic astrocytes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Juan Carlos Cutrin, University of Turin, Italy
Reviewed by: Qifan Zhu, AbbVie’s Cambridge Research Center, United States; Krzysztof Guzik, Jagiellonian University, Poland
This article was submitted to Inflammation, a section of the journal Frontiers in Immunology
These authors have contributed equally to this work and share first authorship
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2021.688674